Effects of gadolinium on N-methyl-D-aspartate (NMDA)-induced centrogenic arrhythmias

Res Commun Chem Pathol Pharmacol. 1992 Nov;78(2):219-23.

Abstract

In urethane-anesthetized rats, the intracerebroventricular (i.c.v.) administration of N-methyl-D-aspartate (NMDA)-induced central arrhythmias. These cardiac rhythm disorders could be prevented by the i.c.v. microinjection of gadolinium, an inhibitor of exocytosis. These findings suggest that inhibition of central neurotransmitter exocytosis could protect against centrogenic arrhythmias.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anesthesia
  • Animals
  • Arrhythmias, Cardiac / chemically induced
  • Arrhythmias, Cardiac / prevention & control*
  • Brain / drug effects
  • Brain / metabolism
  • Exocytosis / drug effects
  • Female
  • Gadolinium / administration & dosage
  • Gadolinium / pharmacology*
  • Heart Rate / drug effects
  • Injections, Intraventricular
  • Male
  • N-Methylaspartate / administration & dosage
  • N-Methylaspartate / antagonists & inhibitors*
  • Neurotransmitter Agents / antagonists & inhibitors
  • Rats
  • Rats, Wistar

Substances

  • Neurotransmitter Agents
  • N-Methylaspartate
  • Gadolinium